Oral medications for treating diabetes mellitus in dogs and cats

被引:15
作者
Nelson, RW [1 ]
机构
[1] Univ Calif Davis, Sch Vet Med, Dept Med & Epidemiol, Davis, CA 95616 USA
关键词
D O I
10.1111/j.1748-5827.2000.tb03969.x
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
Five classes of oral hypoglycaemic drugs and two trace minerals used to treat diabetes mellitus in humans are reviewed and current knowledge on the use of these drugs in diabetic dogs anti cats is presented. Oral sulphonylurea drugs stimulate insulin secretion and have been used successfully to treat diabetes in cats but not dogs. Preliminary studies evaluating the efficacy of the biguanide, metformin, in diabetic cats have not been promising. Pharmacokinetic studies have been performed in healthy cats, but clinical studies evaluating the efficacy of the insulin-sensitising drugs, thiazolidinediones, have not been reported, Treatment with the alpha-glucosidase inhibitor, acarbose, improved control of glycaemia in diabetic dogs; similar studies have not been reported in cats, Although chromium picolinate did not improve control of glycaemia in diabetic dogs, vanadium has improved control of the abnormality in diabetic cats.
引用
收藏
页码:486 / 490
页数:5
相关论文
共 48 条
[1]   THE EFFECTS OF CHROMIUM SUPPLEMENTATION ON SERUM GLUCOSE AND LIPIDS IN PATIENTS WITH AND WITHOUT NON-INSULIN-DEPENDENT DIABETES [J].
ABRAHAM, AS ;
BROOKS, BA ;
EYLATH, U .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1992, 41 (07) :768-771
[2]   CHROMIUM, GLUCOSE-TOLERANCE, AND DIABETES [J].
ANDERSON, RA .
BIOLOGICAL TRACE ELEMENT RESEARCH, 1992, 32 :19-24
[3]   Elevated intakes of supplemental chromium improve glucose and insulin variables in individuals with type 2 diabetes [J].
Anderson, RA ;
Cheng, NZ ;
Bryden, NA ;
Polansky, MM ;
Cheng, NP ;
Chi, JM ;
Feng, JG .
DIABETES, 1997, 46 (11) :1786-1791
[4]  
[Anonymous], 1989, INT J BIOSOC MED RES
[5]   Drug therapy - Metformin [J].
Bailey, CJ ;
Turner, RC .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (09) :574-579
[6]   ACARBOSE - AN UPDATE OF ITS PHARMACOLOGY AND THERAPEUTIC USE IN DIABETES-MELLITUS [J].
BALFOUR, JA ;
MCTAVISH, D .
DRUGS, 1993, 46 (06) :1025-1054
[7]   Thiazolidinediones produce a conformational change in peroxisomal proliferator-activated receptor-gamma: Binding and activation correlate with antidiabetic actions in db/db mice [J].
Berger, J ;
Bailey, P ;
Biswas, C ;
Cullinan, CA ;
Doebber, TW ;
Hayes, NS ;
Saperstein, R ;
Smith, RG ;
Leibowitz, MD .
ENDOCRINOLOGY, 1996, 137 (10) :4189-4195
[8]   THE ROLE OF VANADIUM IN THE MANAGEMENT OF DIABETES [J].
BRICHARD, SM ;
HENQUIN, JC .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1995, 16 (08) :265-270
[9]   ORAL VANADYL SULFATE IMPROVES HEPATIC AND PERIPHERAL INSULIN SENSITIVITY IN PATIENTS WITH NON-LNSULIN-DEPENDENT DIABETES-MELLITUS [J].
COHEN, N ;
HALBERSTAM, M ;
SHLIMOVICH, P ;
CHANG, CJ ;
SHAMOON, H ;
ROSSETTI, L .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 95 (06) :2501-2509
[10]  
Cohn LA, 1999, AM J VET RES, V60, P1360